Imaging transcriptomics of brain disorders
Non-invasive neuroimaging is a powerful tool for quantifying diverse aspects of brain structure and function invivo and has been used extensively to map the neural changes associated with different brain disorders. However,most neuroimaging techniques have limited spatiotemporal resolution and offer only indirect measures ofunderlying pathological mechanisms. The recent development of anatomically comprehensive gene-expressionatlases has opened new opportunities for studying the transcriptional correlates of non-invasively measured neuralphenotypes, offering a rich framework for evaluating pathophysiological hypotheses and putative mechanisms.Here, we overview some fundamental methods in imaging transcriptomics and outline their application tounderstanding brain disorders of neurodevelopment, adulthood, and neurodegeneration. Converging evidenceindicates that spatial variations in gene expression are linked to normative changes in brain structure during agerelatedmaturation and neurodegeneration that are in part associated with cell-specific gene expression markersof gene expression. Transcriptional correlates of disorder-related neuroimaging phenotypes are also linked totranscriptionally dysregulated genes identified in ex vivo analyses of patient brains. Modeling studies demonstratethat spatial patterns of gene expression are involved in regional vulnerability to neurodegeneration and the spreadof disease across the brain. This growing body of work supports the utility of transcriptional atlases in testinghypotheses about the molecular mechanism driving disease-related changes in macroscopic neuroimagingphenotypes.